A system for studying the in vitro replication of the genome RNAs of Sendai virus and its defective interfering particle DI-H has been developed. Cytoplasmic extracts of baby hamster kidney cells infected with wild-type Sendai virus or coinfected with wild-type Sendai virus plus DI-H were prepared after lysolecithin treatment at 12 h postinfection. The extracts supported the transcription of six viral mRNAs as well as the replication of the Sendai virus 50S (wild-type) and 14S DI-H genome RNAs and their encapsidation into nucleocapsids in the absence of de novo protein synthesis. RNA replication in vitro represented more than 50% of total RNA synthesis, a relative level higher than that found in the infected cell. The proteins required for Sendai virus RNA replication were present in a soluble protein pool at the time of extract preparation. Depletion of the protein pool by prior treatment of infected cells with cycloheximide inhibited subsequent in vitro genome replication without affecting transcription. The cytoplasmic extract may be separated by high-speed centrifugation into two components: the Sendai virus wild-type and DI-H nucleocapsid templates containing the RNA and associated NP, L, and P proteins and the soluble protein fraction containing primarily the P, NP, and M viral proteins with trace amounts of the L, HN, Fo, and nonstructural C proteins. The isolated intracellular DI-H nucleocapsid template alone cannot replicate its RNA, but when recombined with the Sendai virus soluble protein fraction it catalyzes the replication and encapsidation of viral RNAs. The initiation of RNA replication in vitro can be demonstrated because detergent-disrupted purified DI-H virions replicate both positive-and negative-strand RNAs in the presence, but not in the absence, of the soluble protein fraction from an extract of infected cells.
Sendai virus, a member of the parainfluenza family, contains a negative-strand [(-)-strand] RNA genome with a molecular weight of 5 x 106 (9, 10, 13). The Sendai virus genome RNA is always found associated with virus-specific proteins in the form of a helical nucleocapsid both in the virion and in the infected cell. The major nucleocapsid protein, NP, of 60 kilodaltons (60 kDa), is tightly associated with the RNA genome and renders it ribonuclease resistant. Two other viral proteins, the P (79 kDa) and L (200 kDa) proteins, are less tightly associated with the nucleocapsid and are thought to catalyze the enzymatic functions required for the transcription and replication of the Sendai virus RNA (17, 20, 27) . There are three additional virion structural proteins, HN (72 kDa), Fo (65 kDa), and M (34 kDa), which are associated with the viral envelope (9, 20) .
In infected cells the (-)-strand RNA nucleocapsid serves as the template for the transcription of at least six mRNAs and for the synthesis of a full-length antigenome (+ sense) RNA which is also always found encapsidated in a nucleocapsid (9) . The antigenome RNA then serves as a template for the synthesis of the progeny (-)-strand nucleocapsid-associated RNA. Viral protein synthesis is thought to be required for RNA replication, since the addition of cycloheximide to an infected cell inhibits RNA replication, although there is a 2-to 3-h lag in the inhibition which is thought to be due to the utilization of preformed proteins for continued replication (22) . During the process of maturation by budding through the plasma membrane of the host cell, Sendai virus nucleocapsids containing RNAs of both (+)-and (-)-strand sense are packaged into virions (14) .
To facilitate the study of Sendai virus genome RNA replication, the Sendai virus defective interfering particle DI-H was used extensively for the development and characterization of an in vitro replication system. The DI-H virion contains an RNA genome of 0.5 x 106 Da (14S) which retains only 11% of the wild-type (WT) Sendai virus genome RNA (12) . The DI-H genome consists only of the 5' terminus of the parental virus, representing a portion of the L cistron, and contains copyback termini with a 3' terminus complementary to the 5' terminus (21) . The DI-H particle is thus defective in transcription and requires the presence of WT Sendai virus as helper to provide the mRNAs and proteins necessary for its reproduction. Defective interfering particles, however, do effectively interfere with the replication but not the transcription of the helper WT Sendai virus in a mixed infection (11) . The use of intracellular DI-H nucleocapsids for in vitro RNA replication should therefore provide small templates with 14S RNAs of both the (+)-and (-)-strand sense that are involved specifically in the process of replication.
MATERIALS AND METHODS
Growth and purification of virus. Sendai virus (Harris strain) obtained from R. Lamb (Northwestern University, Evanston, Ill.) was propagated in the allantoic fluid of 9-day embryonated chicken eggs (SPAFAS, Roanoke, Ill. (14) .
Antiserum to the Sendai virus proteins was prepared in rabbits by the method of Roux and Holland (24 DI-H nucleocapsid RNA synthesis occurring from 8 to 14 h postinfection (data not shown).
We have also used similar methodology to test other methods for the preparation of extracts from [3H]uridinelabeled Sendai virus-infected cells at 12 h postinfection. Methods such as Dounce homogenization or the use of nonionic detergents to rupture cells gave significantly reduced yields of all viral RNA products in the extract (data not shown). In addition, we tested the kinetics of in vivo Sendai virus RNA replication in two other cell lines, MadenDarby bovine kidney and LLCMK2, commonly used for Sendai virus infections. In each case the amount of intracellular Sendai virus nucleocapsid RNA was less than 20% of that observed in infected BHK cells up to 14 h postinfection (data not shown). Furthermore, extracts prepared from Sendai virus-infected Maden-Darby bovine kidney or LLCMK2 cells synthesized proportionately less Sendai virus nucleocapsid RNA in the in vitro reaction.
A final feature of the infection protocol used here was that actinomycin D (2 ,ug/ml) was present in the infection medium from 1 to 12 h postinfection. This concentration of actinomycin D effectively inhibits cellular RNA synthesis and actually shortens the latent period of the Sendai virus infection by about 6 h, as was reported previously (22) . This treatment thus facilitated the rapid accumulation of product intracellular Sendai virus nucleocapsids and proteins. The actinomycin D did cause severe cell damage by late times after infection (14 to 16 h postinfection), but at 12 h, >90% of the cells remained attached to the dish and were permeabilized by lysolecithin treatment. The cell extracts for all subsequent experiments were therefore prepared from BHK cells infected with WT Sendai virus or coinfected with WT Sendai virus plus DI-H in the presence of actinomycin D at 12 h postinfection after lysolecithin treatment; these conditions gave the optimal yield of intracellular Sendai virus nucleocapsids and proteins.
In vitro synthesis of WT Sendai virus and DI-H RNAs. To characterize the RNA products synthesized in vitro, cytoplasmic extracts of Sendai virus-infected BHK cells were prepared at 12 h postinfection and incubated with [3H]UTP for various periods. The replication and transcription products were quantitated during the in vitro incubation by analysis on CsCl gradients (12) . This method of analysis is shown, for example, after a 2-h in vitro incubation (Fig. 1A) . The nucleocapsid-associated RNA, the product of the replication reaction, banded at a density of 1.33 g/ml, identical with that of intracellular Sendai virus nucleocapsids (not shown), whereas the mRNAs pelleted to the bottom of the tube. Using this assay for RNA replication, we determined the optimal in vitro reaction conditions by varying the pH and the NH4Cl, DTT, and magnesium acetate concentrations. Quantitation of the levels of RNA synthesis with time showed that under the optimal reaction conditions described above, nucleocapsid RNA synthesis was linear for approximately 2 h, whereas mRNA synthesis was linear for only 90 min (Fig. 1B) To determine the sizes of the products synthesized in vitro, the RNA was isolated and analyzed by acid-ureaagarose gel electrophoresis and compared with Sendai virus RNAs synthesized in the infected cell (Fig. 2) . The six mRNAs and some 50S Sendai virus genome RNA were synthesized in vitro and were identical in size to the Sendai virus RNAs found in infected cells (Fig. 2 IA, IIA) . Treatment of the reaction products with micrococcal nuclease degrades the mRNAs; however, the 50S genome RNA product was resistant to nuclease, confirming its encapsidation in vitro, like in vivo, into a nucleocapsid structure (Fig.  2 IB, IIB) . Several nuclease-resistant RNAs migrating more slowly than the full-length 50S genome RNA were also synthesized in vitro. Similar RNA products were also seen in vivo, although at much lower levels (Fig. 2 IB) .
In similar experiments, the total products synthesized in extracts of cells coinfected with WT Sendai virus plus DI-H at low levels of interference were identical to the RNA products synthesized in vivo (Fig. 2 IC, IIC) . In addition to the six mRNAs and the 50S genome RNA, there was the in vitro synthesis of the 14S DI-H genome RNAs. The acidurea-agarose gel system is not fully denaturing and will separate the (+)-and (-)-sense RNA strands of the DI particle of another (-)-strand RNA virus, vesicular stomatitis virus (7) . The two 14S bands observed here probably also represent the (+)-and (-)-sense strands of the DI-H RNAs, although the strand sense of each band has not been identified. The newly replicated DI-H genome RNAs were encapsidated in vitro, like in vivo, since they are nuclease resistant (Fig. 2 ID, IID) . Furthermore, after quantitation, these data as well as results of other experiments show that in vitro 14S DI-H RNA synthesis was nearly the same (within 10%) in both the subsequently untreated and micrococcal nuclease-treated samples. This shows that virtually all the 14S RNA synthesized was also encapsidated in these reactions. RNA replication will therefore be defined as RNA synthesis and encapsidation and will subsequently be measured mostly by the quantitation of micrococcal nuclease-resistant RNA products.
Although we did observe some synthesis of the 50S genome RNA in vitro, the amounts were often variable, with many incomplete products. The treated with cycloheximide (100 ptg/ml) for 1 to 3 h before the preparation of the extract. The RNA products were quantitated after centrifugation on CsCI gradients as described in the text by determining the acid-precipitable radioactivity in the gradient fractions containing the nucleocapsid-associated RNA and in the pelleted mRNA. The data for each RNA species are presented as a percentage of the control sample without cycloheximide treatment (100%).
synthesis by >78% without significantly affecting mRNA synthesis ( Table 2) . After 3 h of cycloheximide pretreatment, mRNA synthesis was inhibited only by 27%, whereas nucleocapsid synthesis was reduced by 94%. These data showed that a preformed pool of viral proteins which could be depleted by cycloheximide pretreatment was required for the in vitro replication and encapsidation of Sendai virus genome RNAs.
Reconstitution of the in vitro replication reaction. As a first step toward the characterization of the components essential for in vitro Sendai virus RNA replication, extracts of BHK cells infected with WT Sendai virus plus DI-H (at high levels of interference) were fractionated by high-speed centrifugation as described above. The pellet contained the DI-H and a small amount of WT Sendai virus nucleocapsid templates with their associated L and P proteins, and the remaining supernatant fluid was designated the Sendai soluble protein fraction. The in vitro RNA replication activity of the components in various combinations were tested by incubation with [3H]UTP (Fig. 3) . There was little or no replication of DI-H nucleocapsids in the absence of added proteins (Fig.  3A) , but RNA replication and encapsidation, as demonstrated by the synthesis of the nuclease-resistant 14S DI-H RNAs, was restored by the addition of the Sendai soluble protein fraction (Fig. 3B) . These data show that RNA replication and encapsidation may be reconstituted after fractionation of infected cell extracts and was, in fact, dependent on soluble proteins found in the cytoplasm of infected cells.
To examine the components of the Sendai soluble protein fraction, Sendai virus-infected cells were labeled with
[3H]leucine. A cytoplasmic cell extract was prepared and fractionated by centrifugation as described above. Analysis by polyacrylamide gel electrophoresis showed that, compared with the virus marker (Fig. 4A) , Sendai viral proteins were present in the total soluble protein fraction (Fig. 4B) . Immunoprecipitation of the soluble protein fraction with anti-Sendai virus sera showed that the predominate viral proteins in the soluble protein fraction are the NP, P, and M proteins (Fig. 4C) . On longer exposure of the gel, the glycoproteins HN and Fo, as well as L protein, were also found in the immunoprecipitated sample but were present in only trace amounts. In other experiments, involving the use of 13% polyacrylamide gels (16), the Sendai virus nonstructural C protein was also found to be present in the soluble protein fraction of infected cells (data not shown). Quantitation of the relative levels of the viral proteins in the cytoplasmic extract and the soluble protein fraction showed that about 20% of the NP, P, M, and C proteins in the cytoplasmic extract were in a soluble form (data not shown). We are currently investigating which of these soluble viral proteins are essential for the replication and encapsidation of the Sendai virus genome RNAs in the in vitro replication system.
Initiation of DI-H genome RNA replication in vitro. The templates used in the reconstitution reactions described above were the nucleocapsid RNAs pelleted from cells coinfected with WT Sendai virus plus DI-H for 12 h. These intracellular nucleocapsids would probably contain nascent RNA chains already in the process of replication, and so this reaction might represent only the in vitro elongation of the preinitiated RNAs. To directly test whether the initiation of genome replication could also occur in vitro, detergent-disrupted purified DI-H virions which should not contain initiated RNA chains were used as templates in the in vitro replication reaction. The virus preparation used here was in fact a mixture of WT Sendai and DI-H virions purified from the defective stock which is greatly enriched for DI-H particles. (14) . The detergent-disrupted DI-H virions gave no RNA replication and encapsidation in the absence of added proteins (Fig. 5A) , as expected; however, the addition of the Sendai soluble protein fraction did support the initiation and complete synthesis of nucleocapsidassociated (+)-and (-)-strand DI-H RNAs (Fig. SB) . Thus, the proteins required for the initiation of Sendai virus genome replication from both RNA strands were present in the Sendai soluble protein fraction. DISCUSSION We describe here an efficient cell-free system for the in vitro replication and encapsidation of the genome RNAs of Sendai virus, a prototype of the parainfluenza group, and its defective interfering particle DI-H. In developing this system, we took advantage of the methodology described previously (19) for an in vitro RNA replication system for vesicular stomatitis virus (VSV), a (-)-strand RNA virus of the rhabdovirus group. A key feature for successful in vitro VSV genome RNA synthesis was the treatment of infected cells with lysolecithin before extract preparation, followed by simply pipetting the cells and removing nuclei by low- speed centrifugation. This methodology developed for VSV also proved the best for studying Sendai virus RNA replication. Both systems utilize cytoplasmic extracts prepared from lysolecithin-permeabilized virus-infected BHK cells to catalyze the initiation and replication of genome RNAs. Further characterization of the individual components required for the in vitro replication of these two (-)-strand RNA viruses may then allow us to compare and contrast the mechanism(s) of RNA replication for the rhabdo-and parainfluenza virus groups.
Extracts prepared from Sendai virus-infected cells at 12 h postinfection, which is the time of maximal in vivo RNA replication, catalyze the replication and encapsidation of Sendai virus genome RNA, as well as the synthesis of the viral mRNAs in the absence of de novo protein synthesis ( Fig. 1B and 2) . Six viral mRNAs have been tentatively identified by their ribonuclease sensitivity and labeled 1 through 6 by increasing size. Based on the sizes of the proteins and RNAs, these mRNAs probably code for the M (34 kDa), NP (60 kDa), Fo (65 kDa), HN (74 kDa), P + C (79 kDa + 
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The total amount of RNA synthesis in extracts of Sendai virus-infected cells was two-to threefold greater than that for an equivalent extract of VSV-infected cells. This could reflect either a greater intrinsic replication activity of Sendai virus or perhaps a difference in the amount of intracellular nucleocapsid templates in the two systems. This result was somewhat surprising, since it had been previously shown that in vitro transcription from purified parainfluenza viruses was much poorer than that from purified VSV (6) . Sendai virus genome replication, moreover, occurred at a higher relative level in vitro (50 to 60% of total RNA synthesis) than in the infected cell (40 to 50% of total RNA synthesis). This may be a reflection either of the preferential synthesis of the RNA replication product in vitro or of the greater stability of the nucleocapsid RNA versus mRNA in the reaction.
The SOS WT Sendai virus RNA synthesized and encapsidated in the in vitro replication reaction appeared as a ladder of partially completed, micrococcal nuclease-resistant RNAs up to the size of genome RNA (Fig. 2 IIB) . The majority of the RNA replication products from WT Sendai virus nucleocapsids were in fact smaller than SOS. Similar results were also observed in a different Sendai virus in vitro replication system (20) . It appears that these incomplete, yet distinct, RNAs may represent specific pause sites in the replication process in vitro, and this was also observed to a lesser extent in vivo. In contrast, only full-length, nuclease-resistant RNAs were synthesized in vitro, with intracellular DI-H nucleocapsids as templates (Fig. 2 IID) . Perhaps this difference compared with that in the WT Sendai virus replication reaction is due to the small size of the DI-H RNA or to the nature of the sequences contained in the DI-H genome RNA.
An important feature of this Sendai virus in vitro RNA replication system is that the essential components in the cytoplasmic extract can be separated and then recombined and will still retain activity. The cytoplasmic extract could be fractionated by centrifugation into two components: the nucleocapsid template and the soluble protein fractions, both of which were required for RNA replication and encapsidation (Fig. 3) . This successful reconstitution experiment showed that in vitro Sendai virus RNA replication did not require ongoing protein synthesis but instead relied on the use of soluble proteins in the cytoplasm of the infected cells, as had been also found for in vitro VSV RNA replication (19, 25) . Robinson (22) first showed that significant Sendai virus genome replication could occur in infected cells utilizing a pool of virus proteins, in which de novo protein synthesis was inhibited by cycloheximide. Similarly, we showed that infected cells were depleted of viral proteins by the addition of cycloheximide for 2 to 3 h, and an extract prepared from these cells gave a significant reduction of in vitro RNA replication (>85%) without affecting viral transcription ( Table 2) .
The Sendai soluble protein fraction contains primarily the P, NP, and M proteins, with trace amounts of HN, Fo, L, and C proteins as well (Fig. 4) . This protein fraction not only was required for genome RNA synthesis from intracellular nucleocapsid templates, a reaction which probably involves primarily the elongation of RNA chains initiated in the cell, but also was necessary and sufficient for the initiation of RNA synthesis from detergent-disrupted DI-H virion RNAs (Fig. 5) .
The replication reconstitution assay we describe here may now be used to identify the specific viral and possibly host proteins required for Sendai virus RNA replication. In contrast to the system previously reported for Sendai virus genome replication (20) , this in vitro replication system demonstrates the initiation, elongation, and encapsidation of replicating RNA by the soluble protein fraction of Sendai virus-infected cells. The purification of the viral proteins from the soluble protein fraction may allow the elucidation of the minimal protein requirements for Sendai virus RNA replication. By comparison with the data obtained from in vitro VSV replication systems (4, 18, 19) , it will be very interesting to determine whether there are similar or divergent mechanisms for RNA transcription and replication for these different groups of (-)-strand RNA viruses.
